Newsroom

Dr. Santanu Agrahari, IAS, Chief Executive Officer of the Pharmaceuticals & Medical Devices Bureau of India (PMBI), visited the Ethics Group of Companies’ Gurugram warehouse, providing an opportunity to review the organisation’s warehousing and distribution capabilities and engage with the team on strengthening healthcare supply chain operations. During the visit, the Ethics Group team showcased its warehouse infrastructure, operational processes and distribution capabilities supporting healthcare supply chain requirements. The interaction also provided an opportunity to exchange perspectives on operational efficiency, reliability and the evolving needs of healthcare distribution in India. Dr. Agrahari interacted with the Ethics Group team and gained insights into the processes supporting the movement and distribution of pharmaceutical products. The visit highlighted the importance of robust warehousing, efficient distribution networks and coordinated supply chain operations in ensuring timely access to essential medicines. As an end-to-end supply chain partner for the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), Ethics Group of Companies continues to support healthcare distribution through its warehousing, handling and nationwide supply chain capabilities. The visit further strengthened the ongoing engagement between PMBI and Ethics Group, while providing an opportunity to discuss ways to contribute to a more efficient, reliable and accessible healthcare supply chain across India. Ethics Group of Companies expresses its appreciation to Dr. Santanu Agrahari, IAS, for visiting the Gurugram facility and for the valuable interaction with the team.

Ethics Group of Companies participated in iPHEX 2026 at Bharat Mandapam, New Delhi, engaging with pharmaceutical leaders, manufacturers, distributors and healthcare businesses throughout the three-day industry event. Across the event, held in September 2026, the Ethics Group team used the platform to understand evolving business requirements, discuss industry challenges and explore opportunities across the pharmaceutical value chain. Representing its integrated capabilities across healthcare and supply chain services, Ethics Group of Companies focused its conversations around four key areas: Pharmacy Retail Chain, Nationwide Distribution, Market Entry for Global Brands and Global Sourcing. Industry Conversations Focused on Source-to-Market Efficiency The first day of iPHEX 2026 marked the beginning of extensive discussions at the Ethics Group stall, with visitors from across the pharmaceutical and healthcare ecosystem exploring ways to build stronger and more efficient routes from source to market. The Ethics Group team engaged with manufacturers, distributors and other industry stakeholders to understand their operational requirements and identify potential areas for collaboration. Discussions covered the importance of connected supply chain capabilities, market access and efficient distribution networks in supporting pharmaceutical businesses. Discussions Progress from Introductions to Business Requirements As the event progressed into its second day, conversations at the Ethics Group stall moved beyond introductions and focused increasingly on specific business requirements, operational challenges and potential opportunities. The team continued discussions around pharmacy retail networks, nationwide distribution capabilities, global brand market entry and sourcing solutions, while gaining insights into the evolving needs of pharmaceutical businesses operating across domestic and international markets. These interactions provided an opportunity to explore how integrated capabilities can help businesses create more connected and efficient pathways from source to market. Three Days of Industry Engagement The third and final day brought the three-day participation at iPHEX 2026 to a close. Over the course of the event, the Ethics Group team connected with a diverse range of pharmaceutical and healthcare stakeholders, gaining a deeper understanding of market requirements and emerging business opportunities. The event also provided a platform to establish new industry connections, exchange perspectives and discuss practical opportunities across different stages of the pharmaceutical value chain. The Ethics Group of Companies showcased its focus on supporting businesses through integrated solutions spanning pharmacy retail chains, nationwide distribution, global brand market entry and global sourcing. Strengthening Industry Partnerships Participation at iPHEX 2026 reflects Ethics Group’s continued engagement with the pharmaceutical industry and its focus on developing long-term business relationships. The discussions held during the event highlighted the importance of integrated capabilities, market understanding and reliable execution in building efficient healthcare supply chains. Ethics Group extends its appreciation to everyone who visited Stall 5A-41 & 5A-42 during iPHEX 2026, as well as the organisers, industry partners and stakeholders who contributed to the three days of meaningful engagement. With the event concluded, the conversations, relationships and opportunities initiated at iPHEX 2026 will continue to support future business discussions and collaborations across the pharmaceutical and healthcare ecosystem.

Ethics Express, a division of the Ethics Group of Companies, has successfully inaugurated its Rail Parcel Services on 6 September 2026 at Hazrat Nizamuddin Railway Station, Delhi, marking a significant step in strengthening time-sensitive freight connectivity between Delhi and Mumbai. The service operates via the August Kranti Tejas Rajdhani Express (12954/12953), providing businesses with a dedicated rail-based parcel solution designed around speed, reliability, and predictable transit. The newly launched service offers: Under 24 hours — Door-to-door delivery 16 hours — Station-to-station transit 24 tonnes — Dedicated parcel van in each direction Daily operations — Round-trip connectivity between Delhi and Mumbai With dedicated parcel capacity operating between Hazrat Nizamuddin, Delhi, and Mumbai Central, Ethics Express aims to provide businesses with a faster and dependable alternative for moving time-sensitive shipments along one of India's key commercial corridors. The launch reinforces Ethics Group's commitment to developing integrated, technology-enabled, and customer-focused logistics solutions that address the evolving transportation needs of businesses across India. With its focus on speed, operational reliability, and daily connectivity, Ethics Express is strengthening the role of rail in modern business logistics.  

Ethics Express, a division of Ethics Group of Companies, officially inaugurated its Rail Parcel Services on 5 September 2026 at Mumbai Central Railway Station, marking the commencement of daily commercial operations on the Mumbai–Delhi–Mumbai corridor via the August Kranti Tejas Rajdhani Express (12953/12954). The launch marks a significant step in Ethics Group’s efforts to provide businesses with faster, reliable, and technology-enabled rail logistics solutions. The dedicated service is designed to support time-sensitive business shipments while offering greater predictability and shipment visibility. The Rail Parcel Service provides: Under 24 hours: Door-to-door delivery 16 hours: Station-to-station transit Daily: Round-trip operations 24 tonnes: Dedicated parcel van in each direction Real-time: Barcode-based shipment tracking With dedicated parcel capacity and technology-enabled tracking, Ethics Express aims to strengthen connectivity between two of India's major commercial centres while providing businesses with an efficient alternative for time-sensitive parcel movement. The inauguration represents an important milestone for Ethics Express and reinforces Ethics Group’s commitment to developing trusted, efficient, and dependable rail-based logistics solutions. With daily commercial operations now underway, Ethics Express looks forward to supporting businesses with faster movement, greater visibility, and dependable connectivity between Mumbai and Delhi.

It was a proud moment for Team Ethics to be part of the 7th ACFI World Conclave 2026, held on 12 and 13 August 2026 at Hotel Taj Palace, New Delhi, one of the most respected gatherings in the air cargo and logistics industry.We are honoured to share that Mr. Vipan Jain, Director, Revenue and Business Development, was felicitated at the Conclave. The recognition was presented by Mr. Rajiv Bansal, former Secretary, Ministry of Civil Aviation, and former Chairman and Managing Director, Air India.We are equally proud that Team Ethics Group of Companies was recognised in the Digitization category for its contribution to the air cargo and logistics industry. This honour belongs to every member of the team, and it reflects the dedication, teamwork and commitment that define the way we work.The Conclave brought together an exceptional cross section of industry leadership, including Mr. Pradeep Panicker, Chief Executive Officer, Delhi International Airport (DIAL), along with senior leaders from across the air cargo and aviation ecosystem.Our sincere thanks to Air Cargo Forum India for the invitation and for creating a platform that continues to strengthen dialogue, collaboration and growth across the industry. We look forward to contributing to the journey ahead.

The Ethics Group of Companies participated in the Surat Chemists & Druggists Association event held on 26 July 2026, joining leading pharmacists, chemists, distributors, and healthcare professionals from across the region. The event served as a valuable platform for industry engagement, enabling meaningful discussions on the evolving healthcare and pharmaceutical landscape. During the event, the Ethics Group team showcased its integrated healthcare supply chain capabilities, highlighting expertise in pharmaceutical warehousing, nationwide distribution, technology-enabled logistics, and end-to-end supply chain management. Visitors to the Ethics Group stall interacted with the team to explore how the company's robust infrastructure, operational excellence, and digital solutions are supporting the efficient movement of healthcare products across India. The discussions also focused on strengthening collaboration with healthcare stakeholders and addressing the industry's growing demand for reliable, scalable, and compliant logistics solutions. Participation in the event reflects Ethics Group's continued commitment to supporting India's healthcare ecosystem by delivering efficient, technology-driven, and future-ready supply chain solutions that enhance operational efficiency and improve healthcare accessibility. The company expressed its appreciation to the Surat Chemists & Druggists Association for organising the event and thanked all visitors, partners, and industry professionals who engaged with the team. Ethics Group looks forward to building stronger partnerships and contributing to the continued advancement of India's healthcare supply chain.